← Product Code [MOS](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MOS) · K122646 # DS BREAST 16CH I/T 1.5T DS BREAST 16CH I/T 3.0T (K122646) _Invivo Corporation · MOS · Nov 2, 2012 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MOS/K122646 ## Device Facts - **Applicant:** Invivo Corporation - **Product Code:** [MOS](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MOS.md) - **Decision Date:** Nov 2, 2012 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.1000 - **Device Class:** Class 2 - **Review Panel:** Radiology ## Intended Use The coil is indicated for use on the order of a physician, in conjunction with Philips 1.5T and 3.0T MR scanners as an accessory to produce images of the breast, chest wall and axillary tissue, as an aid to diagnosis. The coil permits MR-guided breast biopsy and localization of lesions. ## Device Story The dS Breast 16ch I/T 1.5T and 3.0T are receive-only radio frequency (RF) coils designed for use with Philips MRI systems. The device functions as an accessory to the MRI system's body coil, which transmits RF signals; the dS coil receives the resultant RF signals from excited nuclei to generate high-resolution diagnostic images. It supports unilateral and bilateral imaging of breast, chest wall, and axillary tissue. The device is used in clinical settings by healthcare professionals to aid in diagnosis and to facilitate MR-guided breast biopsy and lesion localization. By providing high-resolution imaging, the coil assists clinicians in identifying and targeting tissue for biopsy, potentially improving diagnostic accuracy and procedural guidance for patients. ## Clinical Evidence Bench testing only. Evidence includes Signal-to-Noise (SNR) ratio measurements, image uniformity assessments, and evaluation of clinical images to demonstrate performance comparable to predicate devices. Electrical safety testing was performed per IEC standards. ## Technological Characteristics Receive-only RF coil for 1.5T and 3.0T MRI systems. Fundamental technology involves receiving RF signals from tissue. Electrical safety tested per IEC standards. No software algorithm or complex connectivity described. ## Regulatory Identification A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information). ## Special Controls *Classification.* Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. ## Predicate Devices - Breast Biopsy Coil (BBC) ([K032576](/device/K032576.md)) - Breast Biopsy Coil (BBC) (K041) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K122646 1 - 110 # 510(k) Summary of Safety and Effectiveness dS Breast 16ch I/T Submitted By: Invivo Corporation 3545 SW 47th Avenue Gainesville, FL 32608 2 899 1 NOV August 29, 2012 Date: Contact Person: Lisa Simpson, Regulatory Affairs Engineer Tel: (352) 336-0010, ext. 164 Fax: (352) 336-1410 Proprietary Names: dS Breast 16ch I/T 1.5T dS Breast 16ch I/T 3.0T Common Name: Coil, Magnetic Resonance, Specialty Classification Name and Reference: 21 CFR 892.1000 A magnetic resonance diagnostic device, for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance, class II. Device Product Code and Panel Code: MOS / Radiology / 90 ### Device Description: The dS Breast 16ch I/T 1.5T and dS Breast 16ch I/T 3.0T coils are designed for use with a Magnetic Resonance Imaging (MRI) system. The coil is designed to work in unison with the Body Coil of the MRI system, which will transmit the radio frequency (RF) signals, so that the coil may receive the resultant RF signal from the excited nuclei. The coils are designed as receive only coil for high resolution diagnostic imaging and intervention of breast. The coil provides both unilateral and bilateral images (Left, Right and Both) of the anatomy of interest and permits MR-guided biopsy and localization of lesions. ### Indications for Use: The coil is indicated for use on the order of a physician, in conjunction with Philips 1.5T and 3.0T MR scanners as an accessory to produce images of the breast, chest wall and axillary tissue, as an aid to diagnosis. The coil permits MR-guided breast biopsy and localization of lesions. ### Technological Characteristics: The fundamental scientific technology of a radio frequency (RF) coil is that the coil receives radio frequency signals from the tissue of interest. #### Substantial Equivalence Information: When compared to the predicate Breast Biopsy Coil (BBC) devices (K032576 and K041), substantial equivalence of the dS Breast 16ch (1.5 T & 3.0T) devices is based on similarities in intended use, design features, and technological characteristics. Supporting product evaluations includes Signal-to-Noise (SNR) ratio, Image Uniformity and assessment of clinical images. Additionally, the new devices passed electrical safety testing in accordance with IEC standards. > Section 005 Page 1 of 1 {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes entwined around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white. ### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002 Ms. Lisa Simpson Regulatory Engineer Invivo Corporation 3545 S.W. 47th Avenue GAINESVILLE FL 32608 NOV - 2 2012 Re: K122646 Trade/Device Name: dS Breast 16ch I/T 1.5T and dS Breast 16ch I/T 3.0T Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: MOS Dated: August 29, 2012 Received: August 30, 2012 Dear Ms. Simpson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into class II (Special Controls), it may be subject to such additional-controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of - . {2}------------------------------------------------ medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely Yours, Janine M. Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ # Indications for Use Form ## 510(k) Number (if known): K122646 ### Device Name: # dS Breast 16ch I/T 1.5T dS Breast 16ch I/T 3.0T ## Indications for Use: The coil is indicated for use on the order of a physician, in conjunction with Philips 1.5T and 3.0T MR scanners as an accessory to produce images of the breast, chest wall and axillary tissue, as an aid to diagnosis. The coil permits MR-guided breast biopsy and localization of lesions. Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD) Murhus Dökken Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety 510(k) K122646 --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MOS/K122646](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/MOS/K122646) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com